Cargando…
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers
Despite the progress of surgery, radiotherapy, and neoadjuvant chemotherapy, the prognosis for advanced sinonasal cancers (SNCs) remains poor. In the era of precision medicine, more research has been conducted on the molecular pathways and recurrent mutations of SNCs, with the aim of understanding c...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698911/ https://www.ncbi.nlm.nih.gov/pubmed/36431263 http://dx.doi.org/10.3390/jcm11226787 |